Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1856 participants.

Also called NCT02224131

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,856 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02224131
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02224131. Randomized; single masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2020-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling
Acronym
ATIASC
Condition
Embolic Stroke
Intervention (Drug)
Aspirin and clopidogrel
Intervention (Drug)
Aspirin and clopidogrel
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct02224131
Content hash
3a4fc8b626d51dd9913f614edf1c52eadb237a0a02f7d0e89e3557ebc87e4fd3